Evidence map›Paper›PMID 37521620›Full record

ArticleACS omega2023

Determining the Predominant Conformations of Mortiamides A-D in Solution Using NMR Data and Molecular Modeling Tools.

Tanos C C Franca, Arlan da Silva Goncalves, Christopher Bérubé, Normand Voyer, Norman Aubry, Steven R LaPlante

Open access · goldAbstract read
In one paragraph

Article in ACS omega, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Tanos C C FrancaINRS - Centre Armand-Frappier Santé Biotechnologie, Université de Québec, 531 Boulevard des Prairies, Laval, Quebec H7V 1B7, Canada.ORCID https://orcid.org/0000-0002-6048-8103
Arlan da Silva GoncalvesDepartment of Chemistry, Federal Institute of Espírito Santo - Unit Vila Velha, 29106-010 Vila Velha, ES, Brazil.
Christopher BérubéDepartement de Chimie and PROTEO, Faculté des Sciences et de Génie, Université Laval, 1045 Avenue de la Médecine, Québec, Quebec G1V OA6, Canada.
Normand VoyerDepartement de Chimie and PROTEO, Faculté des Sciences et de Génie, Université Laval, 1045 Avenue de la Médecine, Québec, Quebec G1V OA6, Canada.ORCID https://orcid.org/0000-0002-0429-9172
Norman AubryNMR consultant of Steven R. LaPlante's Lab, INRS - Centre Armand-Frappier Santé Biotechnologie, Université de Québec, 531 Boulevard des Prairies, Laval, Quebec H7V 1B7, Canada.
Steven R LaPlanteINRS - Centre Armand-Frappier Santé Biotechnologie, Université de Québec, 531 Boulevard des Prairies, Laval, Quebec H7V 1B7, Canada.
Institut National de la Recherche Scientifique · CAUniversité Laval · CAUniversidade Vila Velha · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Macrocyclic peptidomimetics have been seriously contributing to our arsenal of drugs to combat diseases. The search for nature's discoveries led us to mortiamides A-D (found in a novel fungus from Northern Canada), which is a family of cyclic peptides that clearly have demonstrated impressive pharmaceutical potential. This prompted us to learn more about their solution-state properties as these are central for binding to target molecules. Here, we secured and isolated mortiamide D, and then acquired high-resolution nuclear magnetic resonance (NMR) data to learn more about its structure and dynamics attributes. Sets of two-dimensional NMR experiments provided atomic-level (through-bond and through-space) data to confirm the primary structure, and NMR-driven molecular dynamics (MD) simulations suggested that more than one predominant three-dimensional (3D) structure exist in solution. Further steps of MD simulations are consistent with the finding that the backbones of mortiamides A-C also have at least two prominent macrocyclic shapes, but the side-chain structures and dynamics differed significantly. Knowledge of these solution properties can be exploited for drug design and discovery.

Identifiers

PMID37521620
PMCPMC10373451
OpenAlexW4383896176

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.